Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

The Effect of Motivational Interviewing on Smoking Behavior Among Nursing Students

10 de agosto de 2026 actualizado por: Meral Feratoğlu Research

The Effect of Motivational Interviewing on Changing Smoking Behavior Among Nursing Students

Smoking is one of the leading preventable public health problems worldwide, particularly among young adults who are at increased risk of nicotine dependence. Nursing students represent an important target population because, as future health professionals, they are expected to play a significant role in tobacco control and smoking cessation counseling. The Transtheoretical Model (TTM) is one of the most widely used theoretical frameworks for promoting health behavior change. The aim of this study will be to determine the effect of Transtheoretical Model-based motivational interviewing on changing smoking behavior among nursing students.

This study will be planned as a single-group, quasi-experimental pretest-posttest intervention. Nursing students who smoke cigarettes and voluntarily agree to participate will be included in the study. At baseline, participants will complete a Demographic Information Form, the Fagerström Test for Nicotine Dependence, the Stages of Change questionnaire, the Self-Efficacy/Temptation Scale, the Processes of Change Scale, and the Decisional Balance Scale.

Participants will receive Transtheoretical Model-based educational sessions and motivational interviewing interventions focusing on the health effects of smoking, reasons for smoking, the benefits of smoking cessation, identification of social support resources, relapse prevention strategies, and successful smoking cessation experiences. The Stages of Change questionnaire will be administered before each motivational interviewing session, and all outcome measures will be reassessed during follow-up evaluations. The study is expected to provide evidence regarding the effectiveness of Transtheoretical Model-based motivational interviewing in reducing smoking behavior, decreasing nicotine dependence, promoting progression through the stages of change, improving self-efficacy, enhancing the use of behavioral change processes, and supporting smoking cessation among nursing students.

Descripción general del estudio

Estado

Aún no reclutando

Tipo de estudio

Intervencionista

Inscripción (Estimado)

87

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Sevim Meral Feratoğlu, MSc
  • Número de teléfono: +905346674614
  • Correo electrónico: sevimmeralf@outlook.com

Ubicaciones de estudio

    • Kırklareli
      • Kırklareli, Kırklareli, Turquía (Türkiye), 39100
        • Kırklareli University Faculty of Health Sciences
        • Contacto:

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

No

Descripción

Inclusion Criteria:

  • Nursing students currently enrolled in the study setting.
  • Aged 18 years or older.
  • Current cigarette smokers.
  • No self-reported health condition that would prevent participation in the intervention.
  • Willing and able to provide informed consent and participate in the study.

Exclusion Criteria:

  • Inability to complete all planned stages of the study.
  • Withdrawal of consent or voluntary discontinuation from the study at any time.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: N / A
  • Modelo Intervencionista: Asignación de un solo grupo
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Motivational Interviewing
Participants will receive a Transtheoretical Model-based motivational interviewing intervention designed to promote smoking behavior change and smoking cessation. The intervention will consist of structured face-to-face motivational interviewing sessions delivered in groups, supported by educational content on the health effects of smoking, benefits of smoking cessation, behavior change strategies, social support, relapse prevention, and self-efficacy enhancement. Outcomes will be evaluated using validated questionnaires administered at baseline and follow-up assessments.
Participants will receive a Transtheoretical Model-based motivational interviewing intervention to promote smoking behavior change and smoking cessation. Face-to-face motivational interviewing sessions will be conducted by a researcher trained in motivational interviewing. According to the intervention protocol, participants may receive between two and six sessions depending on their readiness to change, individual needs, and continued participation throughout the study. The intervention will include counseling and education on smoking-related health risks, smoking cessation, motivation enhancement, self-efficacy, behavior change strategies, social support, and relapse prevention. Participants' stage of change will be assessed before each session, and the intervention will be tailored accordingly. Outcomes will be evaluated using validated instruments measuring smoking behavior, nicotine dependence, stages of change, self-efficacy, and behavior change processes.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in Smoking Behavior
Periodo de tiempo: Baseline, Mid-intervention Assessment (1 month), Post-intervention Assessment (2 months)
The primary outcome is the change in smoking behavior following the Transtheoretical Model-based motivational interviewing intervention. Smoking behavior will be evaluated by the average number of cigarettes smoked per day and smoking cessation status.
Baseline, Mid-intervention Assessment (1 month), Post-intervention Assessment (2 months)

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in Nicotine Dependence
Periodo de tiempo: Baseline, Mid-intervention Assessment (1 month later), Post-intervention Assessment (2 months later)
Nicotine dependence will be assessed using the Fagerström Test for Nicotine Dependence (FTND). The total score ranges from 0 to 10, with higher scores indicating a higher level of nicotine dependence.
Baseline, Mid-intervention Assessment (1 month later), Post-intervention Assessment (2 months later)
Change in Processes of Change
Periodo de tiempo: Baseline, Mid-intervention Assessment( 1 month later), Post-intervention Assessment (2 months later)
Behavioral change processes will be assessed using the Processes of Change Scale. The total score ranges from 22 to 110, with higher scores indicating greater use of behavioral change processes related to smoking cessation.
Baseline, Mid-intervention Assessment( 1 month later), Post-intervention Assessment (2 months later)
Change in Self-Efficacy/Temptation for Smoking Cessation
Periodo de tiempo: Baseline, Mid-intervention Assessment (1 month later), Post-intervention Assessment (2 months later)
Self-efficacy related to smoking cessation will be assessed using the Self-Efficacy/Temptation Scale. The scale consists of 8 items rated on a 5-point Likert scale, with a total score ranging from 8 to 40. Higher scores indicate greater self-efficacy and greater confidence in the ability to refrain from smoking in situations that may trigger the urge to smoke.
Baseline, Mid-intervention Assessment (1 month later), Post-intervention Assessment (2 months later)
Change in Decisional Balance
Periodo de tiempo: Baseline, Mid-intervention Assessment (1 month later), Post-intervention Assessment (2 months later)
Decisional balance related to smoking cessation will be assessed using the Decisional Balance Scale. The scale consists of 12 items rated on a 5-point Likert scale, with a total score ranging from 12 to 60. Higher scores indicate greater perceived importance of the benefits and barriers of change and greater engagement in the decision-making process related to smoking cessation.
Baseline, Mid-intervention Assessment (1 month later), Post-intervention Assessment (2 months later)

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

1 de agosto de 2026

Finalización primaria (Estimado)

1 de septiembre de 2026

Finalización del estudio (Estimado)

1 de diciembre de 2026

Fechas de registro del estudio

Enviado por primera vez

5 de agosto de 2026

Primero enviado que cumplió con los criterios de control de calidad

10 de agosto de 2026

Publicado por primera vez (Actual)

11 de agosto de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

11 de agosto de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

10 de agosto de 2026

Última verificación

1 de agosto de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir